As of today (2026-07-05), the Forward Annual Dividend Yield of Thyrocare Technologies is 2.94%.
As of today (2026-07-05), the Trailing Annual Dividend Yield of Thyrocare Technologies is 2.94%.
NSE:THYROCARE's Forward Dividend Yield % is ranked better than 65.08% of 63
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.02
vs NSE:THYROCARE: 2.94
During the past 12 months, Thyrocare Technologies's average Dividends Per Share Growth Rate was 55.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 23.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 18.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Thyrocare Technologies was 49.40% per year. The lowest was -15.70% per year. And the median was 21.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thyrocare Technologies Forward Dividend Yield % Related Terms
NSE:THYROCARE vs TMO, DHR, IDXX: Forward Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Thyrocare Technologies's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thyrocare Technologies Forward Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Thyrocare Technologies's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Thyrocare Technologies Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 7.000000
2026-06-23
2026-06-23
2026-07-29
Cash Dividend
semi-annually
INR:INR 1.000000
INR 2.333333
2025-10-24
2025-10-24
2025-10-30
Cash Dividend
semi-annually
INR:INR 1.000000
INR 7.000000
2025-07-25
2025-07-25
2025-08-05
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.94% mean?
Thyrocare Technologies (NSE:THYROCARE) has a Forward Dividend Yield % of 2.94% as of Jul. 05, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Thyrocare Technologies and its competitors. According to the industry distribution chart, Thyrocare Technologies ranks #22 out of 63 companies in the Medical Diagnostics & Research industry, placing it in the top 34.9%.
Is Thyrocare Technologies' Forward Dividend Yield % too high?
Thyrocare Technologies' current Forward Dividend Yield % is 2.94%. The Medical Diagnostics & Research industry median Forward Dividend Yield % is 2.02. Thyrocare Technologies' value of 2.94% is 45.5% above this industry median. Based on the distribution chart, Thyrocare Technologies ranks #22 out of 63 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Thyrocare Technologies has a GF Score™ of 89/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Thyrocare Technologies' Forward Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Thyrocare Technologies ranks #22 out of 63 companies for Forward Dividend Yield %. This puts Thyrocare Technologies in the upper half of its industry. The industry median Forward Dividend Yield % is 2.02. Thyrocare Technologies' value of 2.94% is 45.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Diagnostics & Research company?
The median Forward Dividend Yield % among Medical Diagnostics & Research companies is 2.02, based on 63 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thyrocare Technologies's current Forward Dividend Yield % of 2.94% is 45.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Thyrocare Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Forward Dividend Yield % is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thyrocare Technologies's current Forward Dividend Yield % is 2.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thyrocare Technologies stock overvalued right now?
Based on GuruFocus' analysis, Thyrocare Technologies (NSE:THYROCARE) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹393.35, compared to a current price of ₹555.60 — trading 41.2% above its estimated fair value. The current Forward Dividend Yield % is 2.94% and 45.5% above the Medical Diagnostics & Research industry median of 2.02. Thyrocare Technologies' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Thyrocare Technologies (NSE:THYROCARE), the current Forward Dividend Yield % is 2.94% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thyrocare Technologies (NSE:THYROCARE) Overvalued in 2026?
Based on GuruFocus' analysis, Thyrocare Technologies stock appears to be overvalued.
The current stock price of ₹555.60 is trading 41.2% above its estimated GF Value™ of ₹393.35.
GuruFocus considers Thyrocare Technologies to be Significantly Overvalued.
Key valuation signals for NSE:THYROCARE:
Forward Dividend Yield %: 2.94%
GF Value™: ₹393.35 vs. price of ₹555.60 (41.2% above fair value)
Industry Position: 45.5% above the Medical Diagnostics & Research median (#22 of 63)
No single metric tells the full story. See the NSE:THYROCARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others: Sale of testing equipment and consumables. The Diagnostic Testing Services segment provides Diagnostic and testing services, selling of consumables used for the collection and promotion of the pathology segment. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates Diagnostic and imaging services, selling of radio-pharmaceuticals, and selling of consumables for reporting. The Other business segment is engaged in the selling of glucometers and glucostrips under the brand name Sugarscan. The company earns the vast majority of its revenue in India.
89GF Score
Get the complete analysis for NSE:THYROCARE
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:THYROCARE has been successfully added to your 